The purpose of this Mentored Patient-Oriented Research Career Development Award (K23) is to provide salary and protected time (up to five years for this award) to support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented
Each Research Career Development Award must be tailored to meet the individual needs of the candidate.
The Translational Scholar Awards in Pharmacogenomics and Personalized Medicine program is intended to address the scarcity of investigators cross-trained in both clinical research core competencies and modern methods required to address pharmacogenomics research problems in patient populations.
Dual mentors from the Clinical and Translational Science Awards consortium and the Pharmacogenomics Research Network are required.
Mechanism of Support.
This FOA will utilize the NIH Research Career Development Award K23 award mechanism.
Funds Available and Anticipated Number of Awards.
For this funding opportunity, the total amount to be awarded will be up to $ 1. 5 M and the anticipated number of awards will be approximately six in FY201 2. The total amount awarded and the number of awards will depend upon the number, quality, duration, and costs of the applications received.